Protein Summary
Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (3' to 5') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase activity. Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also pl ...more
- ENST00000322623
- ENSP00000318297
- ENSG00000175792
- ENST00000643444
- ENSP00000494621
- ENSG00000284901
- INO80H
- NMP238
- TIP49
- TIP49A
- RVB1
- TIH1
- ECP54
- TIP49
- ECP-54
- INO80H
- NMP238
- PONTIN
- TIP49A
- NMP 238
- Pontin52
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
hub protein | 1 | ||
interacting protein | 1 | ||
kinase perturbation | 1 | ||
protein complex | 0.99 | ||
molecular function | 0.94 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 134.43 (req: < 5)
Gene RIFs: 71 (req: <= 3)
Antibodies: 349 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 134.43 (req: >= 5)
Gene RIFs: 71 (req: > 3)
Antibodies: 349 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 28
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0